logo
  

Babcock Says Trading Continues To Be In Line With Board's FY Expectations

Babcock International Group Plc. (BAB.L) said that trading continues to be in line with the Board's expectations for the full year.

In its trading update for the first five months of the year ahead of its Annual General Meeting to be held at 2pm Monday, the company noted that overall group revenue and profit in the first five months of fiscal year 2023 was in line with expectations.

Organic revenue growth is largely offsetting the impact of disposals made in the prior year. Operating profit is being driven by our focus on execution and the efficiencies we are realizing from our new operating model.

The company still anticipates a net cash outflow in the first half of fiscal year 2023, reflecting the timing of pension deficit payments, with a return to positive free cash flow in the second half. Overall, expectations of trading for the full year are unchanged.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
RELATED NEWS
Follow RTT